The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of SGM

29 Jan 2015 14:30

RNS Number : 5171D
CATCo Reinsurance Opps Fund Ltd
29 January 2015
 

 

 

 

CATCo Reinsurance Opportunities Fund Ltd. ("the Company")

Results of Special General Meeting

 

To: SFM, London Stock Exchange and Bermuda Stock Exchange

Date: 29 January 2015

 

 

The Board of CATCo Reinsurance Opportunities Fund Limited (the "Company") is pleased to announce that at the General Meeting of the Company held at 10.00am (Bermuda time) today, both Resolutions set out in the circular to shareholders dated 5 January 2015 (the "Circular") to approve the proposed Return of Value and Share Capital Consolidation were duly passed. The Share Capital Consolidation remains conditional on Admission of the New Ordinary Shares to trading on the Specialist Fund Market and the BSX which is expected to take place on 30 January 2015.

 

Details of the proxy votes received can be found on CATCo Investment Management Ltd's website: www.catcoim.com.

 

The special resolution passed was as follows:

 

Resolution number 1, which related to: (i) the adoption of new Bye-Laws of the Company in substitution for the existing Bye-Laws; (ii) fixing the par value of the B Shares to be created and issued in order to implement the Return of Value (as defined in the circular sent to shareholders on 5 January 2015 (the "Circular")); and (iii) the authority for the Company to take any action or execute any document to give effect to the Return of Value on the terms set out in the Circular).

 

Share Capital Consolidation

Immediately following the issue of B Shares all of the Existing Ordinary Shares will be sub-divided and consolidated into a smaller number of New Ordinary Shares, with the objective of ensuring that the New Ordinary Shares have the same (as is reasonably practicable) Net Asset Value per New Ordinary Share as the Net Asset Value per Existing Ordinary Share on 31 December 2014 as adjusted downwards to reflect the declaration of the Company's annual dividend.

 

The conversion ratio has been determined to be 9 New Ordinary Shares in exchange for every 10 Existing Ordinary Shares held and has been calculated with reference to dividing the Net Asset Value of an Existing Ordinary Share immediately following the issue of the B Shares, which will equal the 31 December Net Asset Value adjusted downwards to reflect the annual dividend and the Return of Value, by the Net Asset Value of an Existing Ordinary Share as at 31 December 2014, adjusted downwards to reflect the Company's annual dividend.

 

It is expected that following the Share Capital Consolidation a total of 273,224,673 New Ordinary Shares will be issued and admitted to trading on 30 January 2015. The ISIN for New Ordinary Shares following the Share Capital Consolidation will be BMG1961Q2095.

 

Following the Share Capital Consolidation, the Company's issued ordinary share capital will consist of 273,224,673 New Ordinary Shares. Accordingly, the total number of voting rights in the Company is 273,224,673. This figure relating to the total number of voting rights in the Company may be used by shareholders in the Company as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Expected timetable

 

Event

Time and/or date, 2015

Latest time and date for dealings in Existing Ordinary Shares. Existing Ordinary Share register closed and Depositary Interests in respect of Existing Ordinary Shares disabled in CREST

5.00 p.m. on 29 January

Record Time for the Share Capital Consolidation and entitlement to B Shares

5.00 p.m. on 29 January

B Shares issued

As soon as practicable after 8.00 a.m. on 30 January

Share Capital Consolidation

Immediately after the B Shares are issued on 30 January

New Ordinary Shares admitted to trading on the Specialist Fund Market and the BSX. Dealings commence in New Ordinary Shares

30 January

CREST accounts for Depositary Interests in respect of New Ordinary Shares credited

As soon as practicable after 8.00 a.m. on 30 January

B Share Dividend becomes payable on B Shares issued pursuant to the Income Alternative

30 January

Redemption of B Shares

30 January

Outstanding B Shares on which B Share Dividend has been paid automatically reclassified as Deferred Shares

30 January

Despatch of share certificates in respect of the New Ordinary Shares

9 February

Despatch of cheques, or if Depositary Interests held in CREST, CREST accounts credited in respect of proceeds under the Capital Alternative

9 February

Despatch of cheques, or if Depositary Interests held in CREST, CREST accounts credited in respect of proceeds under the Income Alternative

9 February

 

Notes:

 

(1) All references to times are references to London times, unless stated otherwise.

 

(2) The dates and times given are indicative only and are based on the Company's current expectations and may be subject to change. If any of the times and/or dates above change, the revised times and/or dates will be notified to the Shareholders by announcement through the Regulatory Information Service.

 

Unless otherwise defined, capitalised words and phrases in this announcement shall have the meaning given to them in the Circular.

 

For further information, please contact:

Judith Wynne

Company Secretary and General Counsel

CATCo Investment Management Ltd

Telephone: +44 7986 205364

Email: judith.wynne@catcoim.com

 

Mark Way

Corporate Communications Director

CATCo Investment Management Ltd

Telephone: +44 7786 116991

Email: mark.way@catcoim.com

 

David Benda / Hugh Jonathan

Numis Securities Limited

Telephone: +44 (0) 20 7260 1000

 

None of the B Shares, Depositary Interests, New Ordinary Shares or Deferred Shares have been or will be registered under the US Securities Act or the state securities laws of the United States and none of them may be offered or sold in the United States unless pursuant to a transaction that has been registered under the US Securities Act and the relevant state securities laws or that is not subject to the registration requirements of the US Securities Act or such laws, either due to an exemption therefrom or otherwise.

 

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

 

This announcement does not constitute, or form part of, an offer to sell or the solicitation of an offer to subscribe for any securities, nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issue or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGSEWFDUFISESF
Date   Source Headline
7th Dec 20154:05 pmRNSIssue of Equity
12th Nov 20159:21 amRNSNet Asset Value(s) & Return of Value Tender Offer
4th Nov 20153:13 pmRNSHolding(s) in Company
3rd Nov 20155:23 pmRNSHolding(s) in Company
2nd Nov 20153:32 pmRNSHolding(s) in Company
29th Oct 20157:00 amRNSResult of Equity Issue and SGM results
16th Oct 20153:58 pmRNSNet Asset Value(s)
2nd Oct 20154:28 pmRNSHolding(s) in Company
29th Sep 20155:02 pmRNSPublication of Prospectus
21st Sep 20157:00 amRNSIssue of Equity
16th Sep 201512:35 pmRNSNet Asset Value(s)
10th Sep 20157:00 amRNSAcquisition
14th Aug 201512:27 pmRNSHalf Yearly Report
14th Aug 20157:00 amRNSNet Asset Value(s)
10th Jul 20157:00 amRNSNet Asset Value(s)
17th Jun 20157:00 amRNSNet Asset Value(s)
15th May 20159:02 amRNSNet Asset Value(s)
7th May 20157:00 amRNSHolding(s) in Company
23rd Apr 20152:47 pmRNSHolding(s) in Company
22nd Apr 20152:50 pmRNSHolding(s) in Company
15th Apr 20157:00 amRNSNet Asset Value(s)
24th Mar 20153:07 pmRNSHolding(s) in Company
24th Mar 201512:37 pmRNSResult of AGM
13th Mar 20157:00 amRNSNet Asset Value(s)
26th Feb 20157:01 amRNSHolding(s) in Company
23rd Feb 20157:00 amRNSNet Asset Value(s)
18th Feb 20152:33 pmRNSDirector/PDMR Shareholding
17th Feb 20153:10 pmRNSAnnual Financial Report
9th Feb 20157:00 amRNSDirectorate Change
29th Jan 20152:30 pmRNSResult of SGM
15th Jan 20157:00 amRNSPortfolio Update
14th Jan 20157:00 amRNSNet Asset Value(s)
5th Jan 20157:00 amRNSDividend Declaration
5th Jan 20157:00 amRNSProposed Return of Value to Shareholders
12th Dec 20147:00 amRNSNet Asset Value(s)
12th Dec 20147:00 amRNSDirectorate Change
11th Nov 20144:47 pmRNSNet Asset Value(s)
14th Oct 20147:00 amRNSNet Asset Value(s)
18th Sep 20143:40 pmRNSHolding(s) in Company
12th Sep 20147:00 amRNSNet Asset Value(s)
14th Aug 20142:41 pmRNSHalf Yearly Report
13th Aug 201412:22 pmRNSNet Asset Value(s)
31st Jul 20142:36 pmRNSHolding(s) in Company
10th Jul 20142:00 pmRNSNet Asset Value(s)
20th May 201411:28 amRNSTransaction in Own Shares
13th May 20147:00 amRNSNet Asset Value(s)
16th Apr 20144:25 pmRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSHolding(s) in Company
10th Apr 20147:00 amRNSNet Asset Value(s)
28th Mar 20142:29 pmRNSAnnual General Meeting Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.